ARLINGTON, VA / ACCESS Newswire / August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global ...

Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these findings, a clear link has yet to be established, and much of the evidence remains ...

Early device failures, prior authorizations, and not receiving 90-days’ worth of supplies contribute to the problem.

A man with type 1 diabetes has produced his own insulin after receiving cell transplant, eliminating the need for ...

Patients with diabetes who use metformin for at least 5 consecutive years are less likely to develop AMD, particularly the ...

New research from the Charles Perkins Center at the University of Sydney has uncovered a new biological pathway that may help ...

According to health experts, herbal teas can interact with your medication and affect your blood sugar levels. That’s why you need to pay close attention ...

Eli Lilly's experimental GLP-1 pill shows promise in a Phase Three trial, helping users lose an average of 12% of body weight, potentially transforming diabetes and obesity treatment.

Knowing beyond all doubt that Mr. Callaghan was innocent and that they had brutalized a man having a medical emergency, these ...

Prevalence of glycemic control and use of diabetes technology lowest in Hispanic, non-Hispanic Black, Medicaid-insured.

GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.